Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin
- 3 December 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 85 (3-4) , 331-333
- https://doi.org/10.1016/0014-2999(82)90220-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2Thrombosis Research, 1982
- Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregationThrombosis Research, 1981
- THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGYThe Lancet, 1981
- INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATIONThe Lancet, 1981
- Effects of an Epoxymethano Stable Analogue of Prostaglandin Endoperoxides (U-46619) on Human PlateletsThrombosis and Haemostasis, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviourThrombosis Research, 1980
- Prostaglandins as Inhibitors of Human Platelet AggregationBritish Journal of Haematology, 1979